Prenatal cell-free DNA screening can be done as early as week 10 of pregnancy.
During the procedure
During prenatal cell-free DNA screening a maternal blood sample is taken and sent to a lab. The lab analyzes the maternal and fetal DNA in the blood sample. A higher than expected ratio of chromosome 21 sequences indicates, for example, the likely presence of trisomy 21 in the fetus. Trisomy 21 is the most common cause of Down syndrome.
Typically, test results are available within two weeks.
Feb. 23, 2016
- AskMayoExpert. Prenatal cell-free DNA screening. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
- American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine. Committee Opinion No. 640: Cell-free DNA screening for fetal aneuploidy. Obstetrics & Gynecology. 2015;126:e31.
- Allyse M, et al. Non-invasive prenatal testing: A review of international implementation and challenges. International Journal of Women's Health. 2015;7:113.
- Prenatal cell-free DNA screening: Q&A for healthcare providers. National Society of Genetic Counselors. http://nsgc.org/page/non-invasive-prenatal-testing-healthcare-providers. Accessed Jan. 6, 2016.
- Prenatal cell-free DNA screening. National Society of Genetic Counselors. http://www.acog.org/Resources-And-Publications/Endorsed-Documents. Accessed Jan. 6, 2016.
- Society for Maternal-Fetal Medicine Publications Committee. #36: Prenatal aneuploidy screening using cell-free DNA. American Journal of Obstetrics and Gynecology. 2015;212:711.
Prenatal cell-free DNA screening